Host: Sarah Thomas, managing director, Deloitte Services LP
In 2020, we have seen personalized and integrated care experiences become mainstream in response to the COVID-19 pandemic. As health care and life sciences organizations continue to advance and evolve, what new developments could emerge in 2021 that will continue to shape the future of health? We’ll discuss:
- Expected trends and issues in 2021.
- Proposed changes health care and life sciences organizations could expect under the new administration.
- The longer-term impacts 2020 has had on the industry.
- How organizations can rethink their growth strategies by finding new areas of opportunity.
Meet the speaker
Dr. Dhar is Vice Chair and US Life Sciences and Health Care (LSHC) Industry Leader for Deloitte LLP leading the overall strategic direction for the life sciences and health care practices, including audit, consulting, tax, and advisory services. He is a respected health futurist and sought-after digital disrupter. Asif helps Governments, Life Sciences and Health Care clients reinvent wellness, solve disease, address pandemics and tackle health inequities. He is also Deloitte’s Lead Partner for the Firm’s US Food and Drug Administration (FDA) relationship and responsible for all work Deloitte performs with and for the Agency. His perspectives on real world evidence, regulatory sciences, digital health, and innovation are sought by clients around the world. Asif’s passion for the LSHC industry is evident in all that he does – as a pioneering thought leader who helped establish a framework for the Future of Health, formed ConvergeHEALTH, an award winning life sciences and health care software solution, and helped frame numerous COVID-19 health-oriented reboot and recovery solutions. He advises some of the world’s most innovative companies and Governmental agencies tackling disease and public health.
Tina is the national sector leader for the health care practice in the US. She leads the overall strategic direction of the health care practice as well as its go-to-market strategies and resources. The sector spans advisory, audit, consulting, and tax practices and is deeply committed to helping our clients navigate the ever-changing health care landscape. She is also the global health care audit leader. With more than 30 years of experience at Deloitte, Tina has managed the delivery of accounting and auditing services to large multi-system health care payor and provider clients. Her consulting experience includes acquisitions, divestitures, and SEC regulatory reporting.
Mike, a principal in Deloitte Consulting LLP, is the national sector leader for Deloitte’s Life Sciences practice. In this role, he leads a multi-disciplinary team who serves clients in the pharmaceutical, biotechnology, medical technology, and consumer health care segments through consulting, advisory, audit, and tax services. Mike is responsible for the overall strategic direction of the life sciences practice as well as its go-to-market strategies and resources. He also serves in the role as life sciences consulting leader. With 20 years of experience dedicated to the life sciences sector, Mike has demonstrated exceptional leadership and practice development. He has led tech and information management teams as well as services at some of our largest biopharmaceutical and medical technology clients, helping them with the definition and implementation of technology and business strategies, related organizational and business alignment. His client work has been presented as examples of leading practices at prominent industry conferences.